Focusing on one of the most aggressive CTC type, which from the primitive tumor spreads to the CNS, we documented that CSF floating cancer cells overexpress syndecan-1, MUC-1 and, in a proportion of cases, the putative stem-cell markers CD15, CD24, CD44, and CD133 in BCLM. This evidence concerns the gene CD44 and cancer.